Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 31 Dec 2024 – 20 Aug 2026, limited by SBI Quant Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | SBI Quant Fund | Nifty 500 |
|---|---|---|
| 31 Dec 2024 | ₹100.00 | ₹100.00 |
| 19 Feb 2025 | ₹91.67 | ₹92.65 |
| 10 Apr 2025 | ₹88.32 | ₹90.98 |
| 29 May 2025 | ₹95.62 | ₹102.17 |
| 18 Jul 2025 | ₹97.96 | ₹104.02 |
| 06 Sep 2025 | ₹94.19 | ₹102.03 |
| 26 Oct 2025 | ₹99.37 | ₹105.86 |
| 14 Dec 2025 | ₹102.88 | ₹106.04 |
| 02 Feb 2026 | ₹104.25 | ₹102.06 |
| 24 Mar 2026 | ₹95.29 | ₹94.15 |
| 13 May 2026 | ₹97.13 | ₹100.01 |
| 01 Jul 2026 | ₹97.92 | ₹103.29 |
| 20 Aug 2026 | ₹100.37 | ₹105.08 |
| Metric | SBI · Direct · IDCW NAV ₹10.02 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +4.69% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +0.23% | +11.82% | |
| +2.76% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 14.77% | 15.88% | |
| -0.12 | 0.35 | |
| -0.17 | 0.47 | |
| -15.02% | -25.18% | |
| Nifty 500 | — | |
| — | +1.40% | |
| — | 0.98 | |
| — | 101.5% | |
| — | 97.0% | |
| 1.62% | 1.14% | |
| ₹3,082Cr | ₹1,162Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 209% | 45% | |
| Sukanya Ghosh | — | |
| 31 Dec 2024 | — | |
| 34 | — | |
| 53.9% | — | |
| 1.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.